Drug Approval | April 18, 2024
Jubilant Pharmova’s Roorkee unit gets VAI status
FDA has concluded that this inspection is 'closed'
FDA has concluded that this inspection is 'closed'
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
_256_384.jpg)
This facility manufactures APIs & formulations of oncology and non-oncology products.
The inspection was conducted from April 8 to April 12, 2024 and concluded with no observations
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The company will respond to the Warning Letter within the stipulated timelines
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
_256_384.jpg)
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
Executes the first project for developing and manufacturing a novel anticancer mAb
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
Subscribe To Our Newsletter & Stay Updated
